Form 4 for EW Edwards Lifesciences
Accepted 2025-05-13 00:00:00 ET · period of report 2025-05-11 · accession 0001225208-25-005052 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-05-13 | 2025-05-13 | EW | Zovighian Bernard J | CEO, Dir | G - Gift | $0.00 | +2,771 | 19.8K | +16% | $0 |
| 2025-05-13 | 2025-05-11 | EW | Zovighian Bernard J | CEO, Dir | F - Tax | $73.68 | -2,860 | 89.6K | -3% | -$210.7K | |
| 2025-05-13 | 2025-05-13 | EW | Zovighian Bernard J | CEO, Dir | G - Gift | $0.00 | -2,771 | 86.8K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-13 | G | A | 2,771 | $0.00 | 19,847 | I | — | — | |
| 2 | Common | Common Stock | 2025-05-11 | F | D | 2,860 | $73.68 | 89,562.55 | D By Trust | — | — | |
| 3 | Common | Common Stock | 2025-05-13 | G | D | 2,771 | $0.00 | 86,791.55 | D | — | — |